Treating Multiple Myeloma by Targeting the NF-Kappa-B Pathway with Gadd45-Beta/MKK7 Inhibitors

Nikhil C Munshi

Genomic Analysis to Gain Insights into Novel and Clinically Relevant Mol

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Kenneth C Anderson

Specialized Program of Research Excellence (SPORE) in Multple Myeloma

Multiple myeloma and immunoproliferative diseases Leukaemia

Hematology and hematologic malignancies Pathology

Richard J Jones

Bone Marrow Transplantation in Human Disease

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia

Hematology and hematologic malignancies

Irene M. Ghobrial

Stroma-mediated clonal evolution in Multiple Myeloma

Multiple myeloma and immunoproliferative diseases

Kelvin P Lee

CD28-Mediated Regulation of Multiple Myeloma Cell Proliferation and Survival

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Timothy A Springer

Integrin-Targeted siRNA Delivery for Therapeutic Gene Silencing in Blood Cancers

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Brenda M Birmann

Diet patterns, aspirin use, obesity and multiple myeloma: a prospective analysis

Multiple myeloma and immunoproliferative diseases

Donna Reece

Expediting Patient-Oriented Research in Canada: Development of Myeloma Canada Research Network (MCRN)

Multiple myeloma and immunoproliferative diseases

Nikhil C Munshi

Role of Combination Therapy with Novel Targeted Agents

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology